Clinical Trials Directory

Trials / Sponsors / Bio-Cancer Treatment International Limited

Bio-Cancer Treatment International Limited

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
UnknownEfficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloi
Acute Myeloid Leukemia
Phase 22016-09-01
CompletedRecombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors
Melanoma, Prostate Adenocarcinoma
Phase 12014-11-01
CompletedPegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of H
Hepatocellular Carcinoma
Phase 22014-04-01
CompletedEfficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Li
Hepatocellular Carcinoma
Phase 22014-04-01
TerminatedA Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lym
Leukemia, Lymphoma
Phase 12012-04-01
CompletedStudy of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)
Neoplasm, Hepatocellular Carcinoma
Phase 1 / Phase 22010-03-01
CompletedStudy of Pegylated Human Recombinant Arginase for Liver Cancer
Neoplasm, Hepatocellular Carcinoma
Phase 12008-05-01